Tohoku Medical and Pharmaceutical University · Faculty of Medicine

Research keywords糖尿病・糖尿病性腎症・急性骨髄性白血病・糖代謝・創薬・分化誘導療法・NASH/NAFLD・ChREBP

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells2018
• The physiological and pathophysiological roles of carbohydrate response element binding protein in the kidney.
• Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells
• Antibody titer 6 months after the third dose of COVID-19 mRNA vaccination

• 急性骨髄性白血病における転写因子ChREBPを介したエネルギー代謝調節機構の解明
• ChREBPを標的とした糖尿病性腎症の新規治療薬の開発

• Official profile